ISELIN, N.J., April 02, 2018 -- UBM Life Sciences Group’s Pharmaceutical Executive today opened nominations for Emerging Pharma Leaders, an awards program that for 10 years has recognized and honored up-and-coming professionals who are vital to the future of the pharmaceutical and biotech industry.
“It’s time again for us to ask, ‘Are you, or is your colleague, a leader in pharma?’” said Lisa Henderson, editor-in-chief of Pharmaceutical Executive. “Every year, nominees and winners find ways to inspire us. It's exciting to highlight their unique skills and qualities.”
Nominations of professionals employed by pharmaceutical or biotech companies will be judged by members of Pharmaceutical Executive’s editorial advisory board, and an Emerging Pharma Leaders alumnus.
“Emerging Pharma Leaders live and work across the world, but all share key qualities,” continued Henderson. “They show willingness to grow. They have the ability to listen. They learn from their mentors, and bring a special enthusiasm to lead their staff and share the load.”
Pharmaceutical Executive will accept nominations through June 30, 2018, reveal this year's winners through a special feature in its October issue, and celebrate their accomplishments with other industry leaders at a special, in-person event in November.
For more information, visit pharmexec.com/leaders2018.
About UBM Americas' Life Sciences Group
UBM Life Sciences is a US-based event, information, and marketing services business serving professional communities in human healthcare, veterinary medicine, and the pharmaceutical industry with an unmatched portfolio of in-person, print, and digital products. The business includes 4 trade shows, over 100 conferences, 30 publications, and over 100 digital products and websites. Reaching over 2 million life sciences professionals monthly, UBM Life Sciences enables the professional communities it serves to learn, connect, and conduct business. UBM Life Sciences is a business unit of UBM Americas, a division of UBM plc.
About UBM plc
UBM plc is the largest pure-play B2B Events organiser in the world. In an increasingly digital world, the value of connecting on a meaningful, human level has never been more important. At UBM, our deep knowledge and passion for the industry sectors we serve allow us to create valuable experiences where people can succeed. At our events people build relationships, close deals and grow their businesses.
Our 3,750+ people, based in more than 20 countries, serve more than 50 different industry sectors—from fashion to pharmaceutical ingredients. These global networks, skilled, passionate people and market-leading events provide exciting opportunities for business people to achieve their ambitions.
For more information, go to www.ubm.com; for UBM corporate news, follow us on Twitter at @UBM.
Media Contacts: UBM Americas - Life Sciences Group Amy Erdman Vice President, Marketing [email protected] (203) 523-7041


BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Capital One Says AML Review Led to Closure of Trump Organization Accounts
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
Apple Restores Telegram to App Store After Content Policy Violation
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight 



